News
-
-
PRESS RELEASE
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Zomedica launches monthly webinar series showcasing innovative products, expert insights, and growth opportunities in animal health. Sessions to feature game-changing technologies for veterinarians, investors, and industry leaders -
-
PRESS RELEASE
Zomedica Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
Zomedica Corp. reports record revenue growth in Q1 2025, driven by strong performance of PulseVet® and TRUFORMA® products. International sales up 32% -
-
PRESS RELEASE
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
Zomedica Corp. launches Equine Asthma Clinical Registry using PulseVet shock wave therapy to offer non-drug treatment alternative for horses; aims to improve patient care with real-world clinical evidence -
-
-
-
PRESS RELEASE
Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth
Zomedica Corp. reports strong financial results for Q4 and FY 2024, with record revenue and growth in Diagnostics segment. Company's focus on accelerated revenue growth in 2025 highlighted